S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Even at $2,000+ Per Share, These 3 Stocks Are Deals
66,000% upside on tiny biotech? (Ad)
Will NIO Partake In China's Economic Awakening?
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
66,000% upside on tiny biotech? (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Tax Software Specialist Vertex In Buy Zone After Base Breakout
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Even at $2,000+ Per Share, These 3 Stocks Are Deals
66,000% upside on tiny biotech? (Ad)
Will NIO Partake In China's Economic Awakening?
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
66,000% upside on tiny biotech? (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Tax Software Specialist Vertex In Buy Zone After Base Breakout
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Even at $2,000+ Per Share, These 3 Stocks Are Deals
66,000% upside on tiny biotech? (Ad)
Will NIO Partake In China's Economic Awakening?
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
66,000% upside on tiny biotech? (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Tax Software Specialist Vertex In Buy Zone After Base Breakout
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Even at $2,000+ Per Share, These 3 Stocks Are Deals
66,000% upside on tiny biotech? (Ad)
Will NIO Partake In China's Economic Awakening?
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
66,000% upside on tiny biotech? (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Tax Software Specialist Vertex In Buy Zone After Base Breakout
NASDAQ:BDTX

Black Diamond Therapeutics (BDTX) Earnings Date, Estimates & Call Transcripts

$1.97
-0.17 (-7.94%)
(As of 06/9/2023 ET)
Compare
Today's Range
$1.96
▼
$2.14
50-Day Range
$1.43
▼
$2.47
52-Week Range
$1.18
▼
$4.08
Volume
45,445 shs
Average Volume
99,820 shs
Market Capitalization
$71.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Aug. 8Estimated
Actual EPS
(Mar. 9)
-$0.59 Beat By $0.04
Consensus EPS
(Mar. 9)
-$0.63
Last Year's Q1 EPS
(3/17/2022)
-$0.71
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

BDTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BDTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Black Diamond Therapeutics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.61)($0.61)($0.61)
Q2 20232($0.63)($0.20)($0.42)
Q3 20232($0.65)($0.20)($0.43)
Q4 20232($0.67)($0.20)($0.44)
FY 20237($2.56)($1.21)($1.89)
Q1 20241($0.19)($0.19)($0.19)
Q2 20241($0.20)($0.20)($0.20)
Q3 20241($0.21)($0.21)($0.21)
Q4 20241($0.20)($0.20)($0.20)
FY 20244($0.80)($0.80)($0.80)

BDTX Earnings Date and Information

Black Diamond Therapeutics last issued its earnings data on March 9th, 2023. The reported ($0.59) earnings per share for the quarter, topping the consensus estimate of ($0.63) by $0.04. Black Diamond Therapeutics has generated ($2.39) earnings per share over the last year (($2.39) diluted earnings per share). Earnings for Black Diamond Therapeutics are expected to grow in the coming year, from ($1.94) to ($1.44) per share. Black Diamond Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 8th, 2023 based off prior year's report dates.

Black Diamond Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/8/2023
(Estimated)		        
3/9/2023Q4 2022($0.63)($0.59)+$0.04($0.59)
11/8/2022Q3 2022($0.64)($0.60)+$0.04($0.60)
8/9/2022Q2 2022($0.68)($0.63)+$0.05($0.63)
5/11/2022Q1 2022($0.75)($0.70)+$0.05($0.70)
3/17/2022Q4 2021($1.01)($0.71)+$0.30($0.71)
11/8/20219/30/2021($0.98)($0.97)+$0.01($0.97)
8/11/20216/30/2021($0.84)($0.95)($0.11)($0.95)
5/7/20213/31/2021($0.67)($0.84)($0.17)($0.84)
3/24/202112/31/2020($0.63)($0.63)($0.63)
11/15/20209/30/2020($0.52)($0.50)+$0.02($0.50)  
8/11/2020Q2($0.4440)($0.41)+$0.0340($0.41)
5/12/2020Q1($0.48)($0.51)($0.03)($0.51)
3/24/2020Q4($1.37)($4.63)($3.26)($4.63)












Black Diamond Therapeutics Earnings - Frequently Asked Questions

When is Black Diamond Therapeutics's earnings date?

Black Diamond Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 8th, 2023 based off last year's report dates. Learn more on BDTX's earnings history.

Did Black Diamond Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Black Diamond Therapeutics (NASDAQ:BDTX) reported ($0.59) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.63) by $0.04. Learn more on analysts' earnings estimate vs. BDTX's actual earnings.

How much profit does Black Diamond Therapeutics generate each year?

Black Diamond Therapeutics (NASDAQ:BDTX) has a recorded net income of -$91.17 million. BDTX has generated -$2.39 earnings per share over the last four quarters.

What is Black Diamond Therapeutics's EPS forecast for next year?

Black Diamond Therapeutics's earnings are expected to grow from ($1.94) per share to ($1.44) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:BDTX) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -